Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes

Diabetes

Volumn 62, Issue 10, 2013, Pages 3589-3598

  Yaghootkar, Hanieh ^a   Lamina, Claudia ^b   Scott, Robert A ^c   Dastani, Zari ^d   Hivert, Marie France ^e,f   Warren, Liling L ^g   Stancáková, Alena ^h   Buxbaum, Sarah G ⁱ   Lyytikäinen, Leo Pekka ^j,k   Henneman, Peter ^l   Wu, Ying ^m   Cheung, Chloe Y Y ⁿ   Pankow, James S ^o   Jackson, Anne U ^p   Gustafsson, Stefan ^q   Zhao, Jing Hua ^c   Ballantyne, Christie M ^r   Xie, Weijia ^a   Bergman, Richard N ^s   Boehnke, Michael ^p   El Bouazzaoui, Fatiha ^l   Collins, Francis S ^t   Dunn, Sandra H ^u   Dupuis, Josee ^v   Forouhi, Nita G ^c   Gillson, Christopher ^c   Hattersley, Andrew T ^a   Hong, Jaeyoung ^v   Kähönen, Mika ^w   Kuusisto, Johanna ^h   Kedenko, Lyudmyla ^x   Kronenberg, Florian ^b   Doria, Alessandro ^y   Assimes, Themistocles L ^z   Ferrannini, Ele ^aa   Hansen, Torben ^ab,ac   Hao, Ke ^ad   Häring, Hans ^ae   Knowles, Joshua W ^z   Lindgren, Cecilia M ^af   Nolan, John J ^ag   Paananen, Jussi ^h   Pedersen, Oluf ^ab,ah,ai,aj   Quertermous, Thomas ^z   Smith, Ulf ^ak   Lehtimäki, Terho ^j,k   Liu, Ching Ti ^v   Loos, Ruth J F ^c,ad   McCarthy, Mark I ^af,al,am   Morris, Andrew D ^an   Vasan, Ramachandran S ^ao,ap   Spector, Tim D ^aq   Teslovich, Tanya M ^p   Tuomilehto, Jaakko ^ar,as,at,au   Van Dijk, Ko Willems ^l   Viikari, Jorma S ^av,aw   Zhu, Na ^o   Langenberg, Claudia ^c   Ingelsson, Erik ^q,af   Semple, Robert K ^ax,ay   Sinaiko, Alan R ^az   Palmer, Colin N A ^an   Walker, Mark ^ba   Lam, Karen S L ⁿ   Paulweber, Bernhard ^x   Mohlke, Karen L ^m   Van Duijn, Cornelia ^bb   Raitakari, Olli T ^av,bc   Bidulescu, Aurelian ^bd   Wareham, Nick J ^c   Laakso, Markku ^h   Waterworth, Dawn M ^g   Lawlor, Debbie A ^be   Meig, James B ^ba   Richards, J Brent ^aq,bf   Frayling, Timothy M ^a   more..

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITÉ DE SHERBROOKE   (Canada)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g GLAXOSMITHKLINE   (United States)

^h UNIVERSITY OF EASTERN FINLAND   (Finland)

ⁱ JACKSON STATE UNIVERSITY   (United States)

^j FIMLAB LABORATORIES   (Finland)

^k TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^l LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^m UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF HONG KONG   (Hong Kong)

^o UNIVERSITY OF MINNESOTA   (United States)

^p UNIVERSITY OF MICHIGAN   (United States)

^q UPPSALA UNIVERSITY   (Sweden)

^r BAYLOR COLLEGE OF MEDICINE   (United States)

^s CEDARS SINAI MEDICAL CENTER   (United States)

^t NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^u UNIVERSITY OF PITTSBURGH   (United States)

^v BOSTON UNIVERSITY   (United States)

^w TAMPERE UNIVERSITY HOSPITAL   (Finland)

^x PARACELSUS MEDICAL UNIVERSITY   (Austria)

^y JOSLIN DIABETES CENTER   (United States)

^z STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aa UNIVERSITY OF PISA   (Italy)

^ab Capital Region   (Denmark)

^ac UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^ad MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^ae UNIVERSITY OF TÜBINGEN   (Germany)

^af UNIVERSITY OF OXFORD   (United Kingdom)

^ag STENO DIABETES CENTER   (Denmark)

^ah HAGEDORN RESEARCH INSTITUTE   (Denmark)

^ai UNIVERSITY OF COPENHAGEN   (Denmark)

^aj AARHUS UNIVERSITY   (Denmark)

^ak UNIVERSITY OF GOTHENBURG   (Sweden)

^al UNIVERSITY OF OXFORD   (United Kingdom)

^am NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^an UNIVERSITY OF DUNDEE   (United Kingdom)

^ao BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ap FRAMINGHAM HEART STUDY   (United States)

^aq KING'S COLLEGE LONDON   (United Kingdom)

^ar NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^as KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^at HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^au DANUBE UNIVERSITY KREMS   (Austria)

^av TURKU UNIVERSITY HOSPITAL   (Finland)

^aw UNIVERSITY OF TURKU   (Finland)

^ax Morehouse School of Medicine ^*  (United Kingdom)

^ay UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^az UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^ba NEWCASTLE UNIVERSITY   (United Kingdom)

^bb ERASMUS MEDICAL CENTER   (Netherlands)

^bc UNIVERSITY OF TURKU   (Finland)

^bd MOREHOUSE SCHOOL OF MEDICINE   (United States)

^be UNIVERSITY OF BRISTOL   (United Kingdom)

^bf MCGILL UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; ADIPOQ PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL;

ARTICLE; CONTROLLED STUDY; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MENDELIAN RANDOMIZATION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME VARIABLE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; FEMALE; GENETIC PREDISPOSITION; GENETICS; GLUCOSE BLOOD LEVEL; MALE; META ANALYSIS; METABOLISM; REGRESSION ANALYSIS; RISK; REVIEW;

ADIPONECTIN; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INSULIN RESISTANCE; MALE; MENDELIAN RANDOMIZATION ANALYSIS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS;

EID: 84891540644     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0128     Document Type: Article

References (58)

1. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-783
2. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009;302:179-188
3. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935
4. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003;289:1799-1804
5. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002;147:173-180
6. Xita N, Tsatsoulis A. Adiponectin in diabetes mellitus. Curr Med Chem 2012;19:5451-5458
7. Wang Y, Zhou M, Lam KS, Xu A. Protective roles of adiponectin in obesityrelated fatty liver diseases: mechanisms and therapeutic implications. Arq Bras Endocrinol Metabol 2009;53:201-212
8. Nawrocki AR, Rajala MW, Tomas E, et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 2006;281:2654-2660
9. Manning AK, Hivert MF, Scott RA, et al.; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium; Multiple Tissue Human Expression Resource (MUTHER) Consortium. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012;44:659-669
10. Gao H, Fall T, van Dam RM, et al. Evidence of a causal relationship between adiponectin levels and insulin sensitivity: a Mendelian randomization study. Diabetes 2012;62:1338-1344
11. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008;27:1133-1163
12. Dastani Z, Hivert MF, Timpson N, et al.; DIAGRAM+ Consortium; MAGIC Consortium; GLGC Investigators; MuTHER Consortium; DIAGRAM Consortium; GIANT Consortium; Global B Pgen Consortium; Procardis Consortium; MAGIC investigators; GLGC Consortium. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012;8:e1002607
13. Warren LL, Li L, Nelson MR, et al. Deep resequencing unveils genetic architecture of ADIPOQ and identifies a novel low-frequency variant strongly associated with adiponectin variation. Diabetes 2012;61:1297-1301
14. Voight BF, Scott LJ, Steinthorsdottir V, et al.; MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010;42:579-589
15. Staiger DO, Stock JH. Instrumental variables regression with weak instruments. Econometrica 1997;65:577-586
16. Stock JH, Wright JH, Yogo M. A survey of weak instruments and weak identification in generalized method of moments. J Bus Econ Stat 2002;20: 518-529
17. Ehret GB, Munroe PB, Rice KM, et al.; International Consortium for Blood Pressure Genome-Wide Association Studies; CARDIoGRAM consortium; CKDGen Consortium; KidneyGen Consortium; EchoGen consortium; CHARGE-HF consortium. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011; 478:103-109
18. Scott RA, Lagou V, Welch RP, et al.; DIAbetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 2012;44:991-1005
19. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010;26:2190-2191
20. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw 2010;36:1-48
21. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558
22. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214- E223
23. Knowles JW, Assimes TL, Tsao PS, et al. Measurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp. Metabolism 2013;62:548-553
24. Greenfield MS, Doberne L, Kraemer F, Tobey T, Reaven G. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 1981;30:387-392
25. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83
26. Gui Y, Silha JV, Murphy LJ. Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes Res 2004;12:1481-1491
27. Alkhateeb A, Al-Azzam S, Zyadine R, Abuarqoub D. Genetic association of adiponectin with type 2 diabetes in Jordanian Arab population. Gene 2013; 512:61-63
28. Wang B, Wang C, Wei D, et al. An association study of SNP + 45 T . G of the AdipoQ gene with type 2 diabetes in Yi and Han people in China. Int J Vitam Nutr Res 2011;81:392-397
29. Li Y, Yang Y, Shi L, Li X, Zhang Y, Yao Y. The association studies of ADIPOQ with type 2 diabetes mellitus in Chinese populations. Diabetes Metab Res Rev 2012;28:551-559
30. Mather KJ, Christophi CA, Jablonski KA, et al.; Diabetes Prevention Program Research Group. Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program. Diabet Med 2012;29:1579-1588
31. Du W, Li Q, Lu Y, et al. Genetic variants in ADIPOQ gene and the risk of type 2 diabetes: a case-control study of Chinese Han population. Endocrine 2011;40:413-422
32. Gong M, Long J, Liu Q, Deng HC. Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis. Mol Cell Endocrinol 2010;325:78-83
33. Sanghera DK, Demirci FY, Been L, et al. PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor. Metabolism 2010;59:492-501
34. Melistas L, Mantzoros CS, Kontogianni M, Antonopoulou S, Ordovas JM, Yiannakouris N. Association of the +45T.G and +276G.T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. Eur J Endocrinol 2009;161:845-852
35. Wang Y, Zhang D, Liu Y, et al. Association study of the single nucleotide polymorphisms in adiponectin-associated genes with type 2 diabetes in Han Chinese. J Genet Genomics 2009;36:417-423
36. Vendramini MF, Pereira AC, Ferreira SR, Kasamatsu TS, Moisés RS; Japanese Brazilian Diabetes Study Group. Association of genetic variants in the adiponectin encoding gene (ADIPOQ) with type 2 diabetes in Japanese Brazilians. J Diabetes Complications 2010;24:115-120
37. Bostrom MA, Freedman BI, Langefeld CD, Liu L, Hicks PJ, Bowden DW. Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy. Diabetes 2009;58: 499-504
38. Hivert MF, Manning AK, McAteer JB, et al. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes 2008;57:3353-3359
39. Cook JR, Semple RK. Hypoadiponectinemia-cause or consequence of human "insulin resistance"? J Clin Endocrinol Metab 2010;95:1544-1554
40. Semple RK, Cochran EK, Soos MA, et al. Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance. Diabetes Care 2008;31:977-979
41. Semple RK, Halberg NH, Burling K, et al. Paradoxical elevation of highmolecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 2007;56:1712-1717
42. Semple RK, Soos MA, Luan J, et al. Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab 2006;91:3219-3223
43. Antuna-Puente B, Boutet E, Vigouroux C, et al. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency. J Clin Endocrinol Metab 2010;95:1463-1468
44. Hattori Y, Hirama N, Suzuki K, Hattori S, Kasai K. Elevated plasma adiponectin and leptin levels in sisters with genetically defective insulin receptors. Diabetes Care 2007;30:e109
45. Basu R, Pajvani UB, Rizza RA, Scherer PE. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 2007;56:2174-2177
46. Imagawa A, Funahashi T, Nakamura T, et al. Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 2002;25:1665-1666
47. Celi F, Bini V, Papi F, et al. Circulating adipocytokines in non-diabetic and Type 1 diabetic children: relationship to insulin therapy, glycaemic control and pubertal development. Diabet Med 2006;23:660-665
48. Leth H, Andersen KK, Frystyk J, et al. Elevated levels of high-molecularweight adiponectin in type 1 diabetes. J Clin Endocrinol Metab 2008;93: 3186-3191
49. Wood AR, Hernandez DG, Nalls MA, et al. Allelic heterogeneity and more detailed analyses of known loci explain additional phenotypic variation and reveal complex patterns of association. Hum Mol Genet 2011;20:4082-4092
50. Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002;277:25863-25866
51. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002;8:731-737
52. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocytesecreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001; 7:947-953
53. Combs TP, Pajvani UB, Berg AH, et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 2004;145:367-383
54. Kim JY, van de Wall E, Laplante M, et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007;117:2621-2637
55. Yamauchi T, Nio Y, Maki T, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007;13:332-339
56. Lihn AS, Ostergard T, Nyholm B, Pedersen SB, Richelsen B, Schmitz O. Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 2003;284: E443-E448
57. Ling H, Waterworth DM, Stirnadel HA, et al. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring) 2009;17:737-744
58. Kilpelainen TO, Zillikens MC, Stancakova A, et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet 2011;43:753-760